Hydropothecary Corp (CVE:THCX) Director Adam Miron sold 133,332 shares of the company’s stock in a transaction on Tuesday, March 6th. The shares were sold at an average price of C$3.95, for a total transaction of C$526,661.40.
Adam Miron also recently made the following trade(s):
- On Thursday, March 8th, Adam Miron sold 100,000 shares of Hydropothecary stock. The shares were sold at an average price of C$3.87, for a total transaction of C$387,000.00.
Shares of Hydropothecary Corp (THCX) traded up C$0.14 on Friday, reaching C$3.99. 1,826,000 shares of the company’s stock traded hands, compared to its average volume of 2,670,000. The stock has a market cap of $713.58 and a PE ratio of -19.95. Hydropothecary Corp has a fifty-two week low of C$1.10 and a fifty-two week high of C$5.25.
Hydropothecary Company Profile
The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.
Receive News & Ratings for Hydropothecary Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydropothecary and related companies with MarketBeat.com's FREE daily email newsletter.